LMR Partners’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.2K Buy
+20,000
New +$31.9K ﹤0.01% 1517

Other funds holding CRDL

LMR Partners's CRDL Position: Q3 2026 in Review

LMR Partners opened a new position in Cardiol Therapeutics (CRDL) in Q3 2026: 20,000 shares worth $33.2K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.

59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • LMR Partners held 20,000 shares of Cardiol Therapeutics worth $33.2K as of Q3 2026.
  • Cardiol Therapeutics was a new LMR Partners position in Q3 2026.
  • Cardiol Therapeutics made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1517 holding.
  • 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.